Turtlemint Fintech Solutions Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report, prepared by CARE Ratings Limited, confirms that the utilization of the company’s Initial Public Offer (IPO) proceeds is in line with the disclosures made in the offer document. The company incurred operating and net losses in recent years, and is navigating potential regulatory changes in the insurance sector.
Monitoring Agency Report Submitted
Turtlemint Fintech Solutions Limited has officially submitted the Monitoring Agency Report for the quarter that concluded on September 30, 2026. This report, meticulously prepared by CARE Ratings Limited, serves to verify the utilization of funds raised through the company’s Initial Public Offer (IPO). The filing addresses the compliance of fund usage against the objectives outlined in the original offer document.
Financial Performance and Operations
The report indicates that the utilization of funds has been consistent with the disclosures made in the offer document. However, it also notes that the company has experienced operating and net losses in the past several years. A significant development mentioned is the release of a public consultation paper by the Insurance Regulatory and Development Authority of India (IRDAI) concerning the economics of insurance distribution, which could impact commission structures and management expenses.
Investment and Proceeds Utilization
Details of the arrangement to monitor the issue proceeds are provided, confirming that fund utilization is as per disclosures. The company has engaged in creating fixed deposits with the proceeds, with certain amounts maturing and being re-invested or credited back. As of September 30, 2026, the total unutilized amount from the IPO proceeds stands at Rs. 641.47 crore, with a substantial portion deployed in fixed deposits and the remainder in various bank accounts.
Progress in Objects and Potential Delays
The report also outlines the progress in the implementation of the IPO objects. While most objects are marked as ‘Ongoing’ with no delays indicated, investments for ‘Funding inorganic growth’ and ‘Investment in wholly owned Subsidiary, TIB, for funding its working capital requirements’ are marked as ‘Yet to Start’, with no specific timelines mentioned in the prospectus for these particular segments.
General Corporate Purposes
Regarding General Corporate Purposes (GCP), the report states that there was Nil utilization in Q2FY27. The company intends to deploy balance Net Proceeds towards GCP, subject to certain caps, including not exceeding 25% of Gross Proceeds for GCP and a cumulative 35% of Gross Proceeds for GCP combined with funding inorganic growth.
Source: BSE
